These Healthcare stocks are trading higher:
-Neurobo Pharmaceuticals Inc (NRBO) stock is trading at $5.72, a gain of $2.45, or 75.23%, on high volume. Neurobo Pharmaceuticals Inc gets a Sentiment Score of Bullish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $36.50. Neurobo Pharmaceuticals Inc next reports earnings on February 11.
-BioRestorative Therapies Inc (BRTX) stock is trading at $2.25, a gain of $0.61, or 37.43%, on high volume. Biorestorative Therapies Inc gets a Sentiment Score of Neutral from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $12.50. Biorestorative Therapies Inc next reports earnings on February 12.
-Akso Health Group - ADR (AHG) stock is trading at $2.05, an increase of $0.41, or 32.32%, on high volume. Akso Health Group ADR gets a Sentiment Score of Bullish from InvestorsObserver.
-Clearmind Medicine Inc (CMND) stock is trading at $1.73, a gain of $0.3, or 21.1%, on high volume. Clearmind Medicine Inc gets a Sentiment Score of Neutral from InvestorsObserver.
Find the top stocks in the Healthcare Sector here.
These Healthcare stocks are trading lower:
-Revelation Biosciences Inc (REVB) stock is trading at $3.31, a drop of $5.49, or 61.42%, on high volume. Revelation Biosciences Inc gets a Sentiment Score of Very Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $343.84. Revelation Biosciences Inc next reports earnings on February 7.
-Caremax Inc (CMAX) stock is trading at $6.62, a loss of $3.68, or 35.79%, on high volume. Caremax Inc gets a Sentiment Score of Very Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $1.50.
-Alaunos Therapeutics Inc (TCRT) stock is trading at $2.01, a loss of $0.52, or 19.73%, on low volume. Alaunos Therapeutics Inc gets a Sentiment Score of Neutral from InvestorsObserver and receives an average analyst recommendation of Buy with a price target of $0.20.
-Vivos Therapeutics Inc (VVOS) stock is trading at $6.35, a loss of $1.02, or 13.84%, on low volume. Vivos Therapeutics Inc gets a Sentiment Score of Neutral from InvestorsObserver. Vivos Therapeutics Inc next reports earnings on February 12.
Find the top stocks in the Healthcare Sector here.